# Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer

> **NCT01772979** · PHASE2 · UNKNOWN · sponsor: **Catholic University of the Sacred Heart** · enrollment: 100 (estimated)

## Conditions studied

- BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype

## Interventions

- **DRUG:** Trabectedin

## Key facts

- **NCT ID:** NCT01772979
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772979, "Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01772979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*